Public trial registry of the CCC-Munich

Trial 26866138MMY3022

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
26866138MMY3022
World
Full title
:

Randomized Phase III Study on Bortezomib and Low-Dose Dexamethasone with or without Continous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma

World
EudraCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C90.0- Multiples Myelom
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.